1. U.S. Department of Health and Human Services, Agency for Health Care Policy and Research (1994) Clinical Practice Guideline; Benign Prostatic Hyperplasia; Diagnosis
2. Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy (eds) (1995) Proceedings of the 3rd International Consultation on Benign Prostatic Hyperplasia (BPH) (level V)
3. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479 (level V)
4. Koyanagi T, Artibani W, Correa R, Desgranchamps F, DeReijke TM, Govier F, Hanash K, Hirano Y, Hoisaeter PA, Kobayashi S, Kurth KH, Marshall VR, Palmtag H, Wasserman N, Zerbib M (1999) Initial diagnostic evaluation of men with lower urinary tract symptoms. In: Proceedings of the 4th International Consultation on Benign Prostatic hyperplasia (BPH) (level V)
5. Oesterling JE, Jacobson SJ, Cooner WH (1995) The use of age-specific reference ranges for serum prostatic antigen in men 60 years old or older. J Urol 153:1160–1163 (level V)